Jazz Venture Partners Activity Every public signal F4 has attached to this firm, with sources and cross-entity links.
Investment
Jazz Venture Partners participated as an existing investor in Transcripta Bio's $24M Series B round alongside Mayo Clinic and Omnimed. The AI-powered drug discovery company focuses on neurological and neuromuscular diseases. Transcripta Bio
Jazz Venture Partners | Activity | F4 3 exits · MAR 2026 – JUL 2026 Show all
Exit
Swing Therapeutics, a Jazz Venture Partners portfolio company developing digital therapeutics for fibromyalgia, was acquired by XRHealth. Swing Therapeutics
Exit
Tomato.ai, a Jazz Venture Partners portfolio company using generative AI to improve human speech for customer support agents, was acquired. Sanas
Exit
Portfolio company Arrive Health exited in March 2026. Arrive Health
Investment
Participated in KLOwen's Series B-II round. KLOWEN
Exit
Portfolio company HerMD was acquired in December 2025. HerMD
Exit
Portfolio company Wisdo was acquired in October 2025. Wisdo
Investment
Invested in Bonito Biosciences, an AI and mRNA display platform for drug discovery. Bonito Biosciences
Exit
AIR, a training platform for humans and AI agents using closed-loop interactions, was acquired. Air
3 investments · FEB 2025 – MAY 2025 Show all Investment
Jazz Venture Partners participated in a $33M Seed round for Cognichip, a company developing cognitive chip technology. CogniChip
Investment
Led pre-seed funding for Sett, a functional oral pouch company designed to support focus and energy. Sett
Investment
Led Series A investment in Justpoint, an AI platform for identifying harmful substances. Justpoint